|
Publication |
|
A comparative analysis of peptide-delivered antisense antibiotics using diverse nucleotide mimics. Ghosh C, Popella L, Dhamodharan V, Jung J, Dietzsch J, Barquist L, Höbartner C, Vogel J. RNA. 2024 May 16;30(6):624-643. doi: 10.1261/rna.079969.124.
|
|
Design and off-target prediction for antisense oligomers targeting bacterial mRNAs with the MASON web server. Jung J, Popella L, Do PT, Pfau P, Vogel J, Barquist L. RNA. 2023 May;29(5):570-583. doi: 10.1261/rna.079263.122. Epub 2023 Feb 7.
|
|
INRI-seq enables global cell-free analysis of translation initiation and off-target effects of antisense inhibitors. Hör J, Jung J, Ðurica-Mitić S, Barquist L, Vogel J. Nucleic Acids Res. 2022 Dec 9;50(22):e128. doi: 10.1093/nar/gkac838.
|
|
Comprehensive analysis of PNA-based antisense antibiotics targeting various essential genes in uropathogenic Escherichia coli. Popella L, Jung J, Do PT, Hayward RJ, Barquist L, Vogel J. Nucleic Acids Res. 2022 Jun 24;50(11):6435-6452. doi: 10.1093/nar/gkac362.
|
|
Global RNA profiles show target selectivity and physiological effects of peptide-delivered antisense antibiotics. Popella L, Jung J, Popova K, Ðurica-Mitić S, Barquist L, Vogel J. Nucleic Acids Res. 2021 May 7;49(8):4705-4724. doi: 10.1093/nar/gkab242.
|
|
| | Last update Publications 02.03.2024 |
|